Strong Membership Growth Boosts Humana
Profits were pressured in the quarter, but we are reiterating our fair value estimate and no-moat rating for the managed-care organization.
Humana (HUM) reported strong membership growth in its third quarter, and impressively, it was able to keep its medical costs in check. We find this a positive development, especially given the firm’s significant skew toward Medicare membership. However, higher operating expenses provided material headwinds as the firm made operating investments to enhance its efficiency. The reinstatement of the health insurer tax did affect the trajectory of these two metrics. Nevertheless, we believe it’s imperative that Humana keep its centralized costs in check, given the high cost of its Medicare cohort and the fluctuation of its medical loss ratio. After factoring in these latest developments, we are reiterating our $215 fair value estimate and no-moat rating for the managed-care organization.
The combination of Humana's exit from the public exchange market and solid underwriting held the firm’s medical loss ratio steady compared with the year-ago period. However, the adjusted operating cost ratio (centralized costs as a percentage of operating revenue) increased by 170 basis points and weighed on profits. Positively, premium and total operating revenue increased for the quarter and were accompanied by a significant increase in membership. We believe the firm continues to benefit from higher-deductible plans, which kept utilization at a lower rate. We find this development highly positive and believe it reflects good underwriting and sales execution. However, the increase in centralized costs is a negative, and we would like to see this trend reverse over the coming quarters. Given the long-term uncertainty that will dominate the health insurance space over the next several years and the firm’s concentration in the lower-profit Medicare Part C market, controlling nonmedical expenses will be essential for Humana in producing long-term economic profits.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Vishnu Lekraj does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.